Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mitosis (MITO) vs iExec RLC (RLC) Price & Performance

MitosisTrade
iExec RLCTrade

Price performance (Past 24H)

Key statistics

Mitosis vs iExec RLC — how do they compare? Mitosis trades at Rp388.48 (market cap Rp70,71M, Rp65,19M 24h volume), while iExec RLC trades at Rp5,293 (market cap Rp462,6M, Rp20,75M 24h volume). The key difference: iExec RLC is far larger — about 6.5× Mitosis's market cap, and Mitosis's circulating supply is 181,3M / 1B MITO (19%) versus 87M / 87M RLC (100%) for iExec RLC. Which is the better fit depends on your goals — on Pluang, investors hold Mitosis for 19 Days and iExec RLC for 34 Days on average.

MITORLC
Market Cap
Rp70,71MRp462,6M
Volume (24h)
Rp65,19MRp20,75M
Circulating Supply
181,3M / 1B MITO (19%)87M / 87M RLC (100%)
Typical Hold Time
19 Days34 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mitosis

MITO is trading at Rp385.97 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The token has a market cap of Rp70.05 million and a low circulation rate of 19%, with key support at Rp352 and resistance at Rp395. Recent news highlights a corporate acquisition of a similarly named entity, but no direct protocol updates were found for the cryptocurrency.

Overall outlook is cautious due to bearish technicals and limited fundamental developments. Key opportunities include potential recovery if support holds, but risks involve low liquidity and minimal ecosystem activity. Investors should monitor for any token-specific news or network updates to reassess positioning.

iExec RLC

iExec RLC is trading at Rp5,298 with a bearish technical outlook, as moving averages signal strong selling pressure while oscillators remain neutral. The token is fully distributed with a market cap of Rp459.05 million, and current price sits between key support at Rp5,076 and resistance at Rp5,341. No major protocol updates or ecosystem developments have been reported recently, leaving technical factors as the primary market driver.

Overall outlook remains cautious with near-term downside risk toward support levels. Key opportunities include potential oversold bounces from support zones, while major risks include continued bearish momentum and low liquidity amplifying volatility. Investors should monitor for any fundamental catalysts that could shift sentiment.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MITO
2% Buy98% Sell
Avg holding period · 19 Days
RLC

No sentiment data available yet.

About Mitosis

Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.

Read more on MITO

About iExec RLC

iExec (RLC) is the leading provider of blockchain-based decentralized computing. Blockchain is utilized to organize a market network where people can monetize their computing power as well as applications and even datasets. iExec can support applications in fields such as big data, healthcare, AI, rendering and fintech. IExec was founded on Oct. 16, 2016, with the goal to reinvent cloud computing through the creation of a new cloud computing paradigm.

Read more on RLC